Iconovo offers license agreements for the development of both novel originator medicine and generics based on Iconovo’s unique patent-protected inhaler platforms. You can get an exclusive license within a certain field for the use of the inhaler platform as a licensee of our patents. Iconovo currently has 16 patent families for five device platforms. And we are constantly adding new inventions and patents to our portfolio.
With the license agreement you will pay Iconovo for the license rights plus an additional license fee once you launch your product.
Buy our inhalers
Another option is to buy the inhaler from Iconovo without exclusivity but still protected by our patent portfolio and you will compensate us for our development services, documentation, and supply. But without exclusivity other companies can also buy inhalers for your API. This option is only available for ICOcap, ICOone and ICOone Nasal.
Possessing a unique combination
of engineering and pharma expertise, Iconovo can provide the optimal combination of customized inhalers and tailored formulations.
Ideon, Delta 6 Lund
SE-223 70 LUND